Sustainable and equivalent improvements in symptoms and functional well-being following viral cure from ledipasvir/sofosbuvir versus elbasvir/grazoprevir for chronic hepatitis C infection: Findings from the randomized PRIORITIZE trial
Journal of Viral Hepatitis
Disclaimer: Publications may either be freely available or require a fee to view (or access) on the journal’s website.
Evon DM, Dong M, Reeve BB, Peter J, Michael L, Lok AS, Nelson DR, Stewart PW. Sustainable and Equivalent Improvements in Symptoms and Functional Well-Being Following Viral Cure from Ledipasvir/Sofosbuvir versus Elbasvir/Grazoprevir for Chronic Hepatitis C Infection: Findings from the randomized PRIORITIZE trial. J Viral Hepat. 2022 Jun 3. doi: 10.1111/jvh.13716. Epub ahead of print. PMID: 35657133.
- Has Results
Journal Article Type
- Paper Resulting From PCORI-Funded Research Study (with results)
- Other Results
Journal Publication Name
- Journal of Viral Hepatitis
- PCORI Research